Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients

Smad4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer

(2011) P. Papageorgis et al.   CANCER RESEARCH

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression

(2011) Zhihu Ding et al.   NATURE

Proteomics of Smad4 regulated transforming growth factor-beta signalling in colon cancer cells

(2010) Naveid Ahmad Ali et al.   Molecular BioSystems

Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma

(2010) Xia Li et al.   TUMOR BIOLOGY

Strong Smad4 Expression Correlates with Poor Prognosis After Surgery in Patients with Hepatocellular Carcinoma

(2009) Kiyokazu Hiwatashi et al.   ANNALS OF SURGICAL ONCOLOGY

Promoter-wide analysis of Smad4 binding sites in human epithelial cells

(2009) Daizo Koinuma et al.   CANCER SCIENCE

SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer

(2009) A. Blackford et al.   CLINICAL CANCER RESEARCH

Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients

(2009) Boqian Sun et al.   JOURNAL OF NEURO-ONCOLOGY

Deleted in pancreatic carcinoma locus 4/Smad4 participates in the regulation of apoptosis by affecting the Bcl-2/Bax balance in non–small cell lung cancer

(2008) Zunfu Ke et al.   HUMAN PATHOLOGY